Alex Matthews

Cardiovascular Specialist covering Alabama and Mississippi

[Victor Dayan @VictorDayan1]

Mean time to redo-TAVI 6 years. That means a 70 year old patient will get TAVI at 70, TAVI in TAVI at 76, TAVI in TAVI in TSVI at 82 (assuming same degeneration rate) and TAVI in TAVI in TAVI in TAVI at 88 ?? Am I the only one seeing this abomination ?

[frank arko @farkomd]

Today, our team continues to push the boundaries of aortic care with Drs. Parodi, Bozso, & Frederick.

✅ First in the USA to offer the Artivion NEXUS Total Arch Device after FDA approval

✅ Expanding one of the nation’s leading aortic programs

✅ Training the next generation

[Endospan @EndospanLtd]

We are proud to announce that Artivion, Inc. (NYSE: AORT) has closed the transaction to acquire our company. This strategic milestone follows the April 2026 U.S. Food and Drug Administration (FDA) PMA approval of the NEXUS® Aortic Arch System, the first off-the-shelf endovascular solution designed to treat aortic arch disease, including chronic aortic dissections, in patients at high risk for open surgical repair.

You can read the full press release and learn more here: https://t.co/a8BhKH8BE4

#NEXUSaorta #totalarch #aorticdissection #aorticarchrepair #aortaEd

[Endovascular Today @EVToday]

Endospan’s Nexus Aortic Arch Stent Graft System Approved by FDA | @EndospanLtd https://t.co/zDdVs5yUCp

[Alex Matthews @AlexMatthews01]

The best aortic valve also resides in his heart!!! OnX!

https://t.co/iWdWdYoU2T

Long, active lives come from thoughtful, informed decisions.

Congratulations, @CoachHoiberg!

[Nebraska Men's Basketball @HuskerMBB]

The nation's best resides in Lincoln.

Coach Hoiberg is your Associated Press National Coach of the Year.

[George Tolis @georgetolisjr]

I have never seen a patient with a failing aortic bioprosthesis placed with a “root enlargement” in the past whose coronaries were high enough to qualify them for a valve-in-valve TAVI.

[Alex Matthews @AlexMatthews01]

@JordanBloomMD Thanks for sharing. Out of curiosity, which valve manufacturer was used in these cases?

[frank arko @farkomd]

DUO

[Alex Matthews @AlexMatthews01]

@AATSHQ Or use AMDS -
0 DANE through 2 years with AMDS, plus stable aortic dimensions & sustained true-lumen expansion enabling malperfusion resolution.
Simple deployment and easy to implant.

[Ioana Florea, MD MPHS @ibflormed]

Fantastic start to afternoon sessions learning from the masters about addressing aortic arch pathology @STS_CTsurgery #sts2026

[Samford University @SamfordU]

Look who showed up on Jeopardy! last night. 😎👀

[George Tolis @georgetolisjr]

These studies remind me of tobacco company-sponsored studies in the 1950s that showed no early mortality differences between smokers and non-smokers.

[Artivion @ArtivionInc]

Mark your calendars for an important webinar: Data-Driven Valve Selection for Younger AVR Patients, featuring @JordanBloomMD, @ChrisMalaisrie and @MarcGerdisch. September 25 at 8 am ET. Click here to register: https://t.co/gQDhFndKsE

[CTSNet @ctsnetorg]

Registration now open! Don’t miss this live webinar where experts will discuss the latest data on AVR, including the STS Database survival outcomes, On-X 5-year PAS results, and how valve selection is evolving for today’s patients.

Register Here: https://t.co/ZrjCdRSTnU

[UAB Medicine @uabmedicine]

Congratulations to the @uabcvi Division of Cardiothoracic Surgery for earning the @STS_CTsurgery highest quality accreditation, a distinction that places UAB Medicine among the top 1% of cardiothoracic surgery programs nationwide.👏

🔗 https://t.co/GT4ZiPeHqt

[George Tolis @georgetolisjr]

Mechanical valves are grossly underutilized in the US. There is a solid body of literature slowly emerging to back up this claim.

[UAB Cardiothoracic Surgery @UABCTSResidency]

Incredible accomplishment!

@UABCVI @Bamamd98 @clifton23526466 @KyleEudaileyMD @pannvar @RootGal210

[Jordan Bloom @JordanBloomMD]

Also amazing wetlab sponsored by @ArtivionInc a company truly dedicated to education and the Ross.

[Alex Matthews @AlexMatthews01]

@PJSpen1982 Yes!! 🗣️

[Alex Matthews @AlexMatthews01]

@GeneralBuckTur2 @georgetolisjr On-X Aortic Valve managed at a low INR of 1.5-2.0 demonstrates an 87% reduction in major bleeding (MB) with no increase in thromboembolism (TE) and no valve thrombosis (VT) when compared to standard INR of 2.0-3.0.

https://t.co/unltpWgbw3